STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $342,000 | -50.1% | 22,300 | -58.2% | 0.00% | -50.0% |
| Q1 2019 | $686,000 | +29.9% | 53,400 | -4.0% | 0.00% | +100.0% |
| Q4 2018 | $528,000 | -68.5% | 55,600 | -44.9% | 0.00% | -75.0% |
| Q3 2018 | $1,675,000 | +6.1% | 100,900 | +2.6% | 0.00% | 0.0% |
| Q2 2018 | $1,578,000 | – | 98,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 453,000 | $4,168,000 | 1.58% |
| Eventide Asset Management | 1,086,400 | $9,995,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $2,760,000 | 0.47% |
| Lyon Street Capital, LLC | 125,595 | $1,155,000 | 0.46% |
| CARL DOMINO INC | 26,000 | $239,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $552,000 | 0.22% |
| KNOTT DAVID M | 41,692 | $384,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 187,500 | $1,725,000 | 0.11% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,157,500 | $10,649,000 | 0.11% |
| Telemetry Investments, L.L.C. | 25,000 | $230,000 | 0.11% |